Early Glycemic Control May Cut CV Risk in Type 2 Diabetes

WEDNESDAY, May 18, 2022 -- Early control of glycated hemoglobin (HbA1c) may improve cardiovascular outcomes in type 2 diabetes, according to a study published online April 4 in Diabetes, Obesity and Metabolism. Martin B. Whyte, Ph.D., from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news